✦ LIBER ✦

Cytokeratin-positive cell dissemination in patients with in situ ductal carcinoma of the breast

✍ Scribed by Ingrid Stelzmueller; Paul Hengster; Peter Obrist; Martina Duenser; Raimund Margreiter; Helmut Weiss

Publisher: John Wiley and Sons
Year: 2005
Tongue: French
Weight: 42 KB
Volume: 114
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.20691

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disseminated tumor cells in the bone mar

Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ

✍ Nicole Sänger; Katharina E. Effenberger; Sabine Riethdorf; Viviane Van Haasteren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB 👁 2 views

## Abstract Detection of disseminated tumor cells (DTCs) in bone marrow is an independent prognostic factor in primary breast cancer. Here, we conducted a proof‐of‐principle study to evaluate whether this tumor cell spread occurs already in patients with ductal carcinoma in situ (DCIS). After preop

Ductal carcinoma in situ of the breast

✍ Harris, Jules E. ;Bruetman, Daniel ;Bloom, Ken ;Bines, Steven 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Tumour-positive sentinel node findings i

Tumour-positive sentinel node findings in patients with ductal carcinoma in situ

✍ M. Leidenius; K. Salmenkivi; K. von Smitten; P. Heikkilä 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

Ductal carcinoma in situ of the male bre

Ductal carcinoma in situ of the male breast

✍ Mauricio G. Camus; Megha G. Joshi; Gasan Mackarem; Arthur K. C. Lee; Ricardo L. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr

Heterogeneity of ductal carcinoma in sit

Heterogeneity of ductal carcinoma in situ of the breast

✍ Michael D. Lagios 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents

Thoughts about ductal carcinoma in situ

Thoughts about ductal carcinoma in situ of the breast

✍ Lawrence, Walter 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Ductal carcinoma in situ (DCIS) was a relatively uncommon disease process when we relied on palpation to detect breast lesions. With the advent of more widespread mammography screenings, the surgeon is faced with a welcome opportunity to prevent cancer by dealing with a precursor lesion. Discovering